Regulation of replicative and stress-induced senescence by RSK4, which is down-regulated in human tumors

Clinical Cancer Research

Volumn 15, Issue 14, 2009, Pages 4546-4553

  López Vicente, Laura ^a,b   Armengol, Gemma ^a,b   Pons, Berta ^a   Coch, Laura ^a   Argelaguet, Elisabet ^a   Lleonart, Matilde ^a   Hernández Losa, Javier ^a   De Torres, Inés ^a   Ramon Y Cajal, Santiago ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; SHORT HAIRPIN RNA;

ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; COLON ADENOMA; COLON CARCINOMA; CONTROLLED STUDY; DOWN REGULATION; FIBROBLAST; GENE EXPRESSION; HUMAN; HUMAN TISSUE; KIDNEY CARCINOMA; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RSK4 GENE; SENESCENCE; TUMOR SUPPRESSOR GENE;

ANTINEOPLASTIC AGENTS; BLOTTING, WESTERN; CELL AGING; CELL LINE; CELL PROLIFERATION; CISPLATIN; COLONIC NEOPLASMS; CYCLIN-DEPENDENT KINASE INHIBITOR P16; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DNA REPLICATION; DOWN-REGULATION; HCT116 CELLS; HUMANS; HYDROGEN PEROXIDE; KIDNEY NEOPLASMS; NEOPLASMS; OXIDANTS; OXIDATIVE STRESS; RETINOBLASTOMA PROTEIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RIBOSOMAL PROTEIN S6 KINASES, 90-KDA; RNA, SMALL INTERFERING; TRANSFECTION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 68049102317     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-08-3159     Document Type: Article

References (41)

1. Herbig U, Sedivy JM. Regulation of growth arrest in senescence: telomere damage is not the end of the story. Mech Ageing Dev 2006;127:16-24. (Pubitemid 41713510)
2. Shay JW, Roninson IB. Hallmarks of senescence in carcinogenesis and cancer therapy. Oncogene 2004;23:2919-2933
3. Serrano M, Lin AW, McCurrach ME, Beach D, Lowe SW. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 1997;88:593-602. (Pubitemid 27152402)
4. Courtois-Cox S, Genther Williams SM, Reczek EE, et al. A negative feedback signaling network underlies oncogene-induced senescence. Cancer Cell 2006;10:459-472 (Pubitemid 44872980)
5. Campisi J, d'Adda di Fagagna F. Cellular senescence: when bad things happen to good cells. Nat Rev Mol Cell Biol 2007;8:729-740
6. Collado M, Blasco MA, Serrano M. Cellular senescence in cancer and aging. Cell 2007;130:223-233
7. Ben-Porath I, Weinberg RA. The signals and pathways activating cellular senescence. Int J Biochem Cell Biol 2005;37:961-976 (Pubitemid 40311739)
8. Campisi J. Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors. Cell 2005;120:513-522 (Pubitemid 40269765)
9. Ben-Porath I, Weinberg RA. When cells get stressed: an integrative view of cellular senescence. J Clin Invest 2004;113:8-13. (Pubitemid 38541623)
10. Brown JP, Wei W, Sedivy JM. Bypass of senescence after disruption of p21CIP1/WAF1gene in normal diploid human fibroblasts. Science1997;277:831-834
11. Bond JA, Wyllie FS, Wynford-Thomas D. Escape from senescence in human diploid fibroblasts induced directly by mutant p53. Oncogene 1994;9:1885-1889 (Pubitemid 24194154)
12. Beausejour CM, Krtolica A, Galimi F, et al. Reversal of human cellular senescence: roles of the p53 and p16 pathways. EMBO J 2003;22:4212-4222 (Pubitemid 37021749)
13. Chen Z, Trotman LC, Shaffer D, et al. Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis. Nature 2005;436:725-730 (Pubitemid 41117277)
14. Xue W, Zender L, Miething C, et al. Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas. Nature 2007;445:656-660 (Pubitemid 46232886)
15. Lin AW, Barradas M, Stone JC, van Aelst L, Serrano M, Lowe SW. Premature senescence involving p53 and p16 is activated in response to constitutive MEK/MAPK mitogenic signaling. Genes Dev 1998;12:3008-3019 (Pubitemid 28469303)
16. Sherr CJ, Bertwistle D,W DENB, et al. p53-Dependent and -independent functions of the Arf tumor suppressor. Cold Spring Harb Symp Quant Biol 2005;70:129-137 (Pubitemid 44124864)
17. Bihani T, Chicas A, Lo CP, Lin AW. Dissecting the senescence-like program in tumor cells activated by Ras signaling. J Biol Chem 2007;282:2666-2675 (Pubitemid 47076800)
18. Di Micco R, Fumagalli M, d'Adda di Fagagna F. Breaking news: high-speed race ends in arrest - how oncogenes induce senescence.Trends Cell Biol 2007;17:529-536
19. Prieur A, Peeper DS. Cellular senescence in vivo: a barrier to tumorigenesis. Curr Opin Cell Biol 2008;20:150-155
20. Bartkova J, Rezaei N, Liontos M, et al. Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints. Nature 2006;444:633-637 (Pubitemid 44864442)
21. Trost TM, Lausch EU, Fees SA, et al. Premature senescence is a primary fail-safe mechanism of ERBB2-driven tumorigenesis in breast carcinoma cells. Cancer Res 2005;65:840-849
22. Michaloglou C, Vredeveld LC, Soengas MS, et al. BRAFE600-associated senescence-like cell cycle arrest of human naevi. Nature 2005;436:720-724 (Pubitemid 41117276)
23. Gorgoulis VG, Vassiliou LV, Karakaidos P, et al. Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions. Nature 2005;434:907-913 (Pubitemid 40559004)
24. Collado M, Gil J, Efeyan A, et al. Tumour biology: senescence in premalignant tumours. Nature 2005;436:642. (Pubitemid 41117258)
25. Braig M, Lee S, Loddenkemper C, et al. Oncogene-induced senescence as an initial barrier in lymphoma development. Nature 2005;436:660-665 (Pubitemid 41117262)
26. Berns K, Hijmans EM, Mullenders J, et al. A large-scale RNAi screen in human cells identifies new components of the p53 pathway. Nature 2004;428:431-437 (Pubitemid 38419689)
27. Frodin M, Gammeltoft S. Role and regulation of 90 kDa ribosomal S6 kinase (RSK) in signal transduction. Mol Cell Endocrinol 1999;151:65-77. (Pubitemid 29295514)
28. Dummler BA, Hauge C, Silber J, et al. Functional characterization of human RSK4, a new 90-kDa ribosomal S6 kinase, reveals constitutive activation in most cell types. J Biol Chem 2005;280:13304-13314 (Pubitemid 40517216)
29. Hauge C, Frodin M. RSK and MSK in MAP kinase signalling. J Cell Sci 2006;119:3021-3023 (Pubitemid 44322115)
30. Niehof M, Borlak J. RSK4 and PAK5 are novel candidate genes in diabetic rat kidney and brain. Mol Pharmacol 2005;67:604-611 (Pubitemid 40365307)
31. Lleonart M, Vidal F, Gallardo D, et al. New p53 related genes in human tumors: significant downregulation in colon and lung carcinomas. Oncol Rep 2006;16:603-608
32. Myers AP, Corson LB, Rossant J, Baker JC. Characterization of mouse Rsk4 as an inhibitor of fibroblast growth factor-RAS-extracellular signal-regulated kinase signaling. Mol Cell Biol 2004;24:4255-4266 (Pubitemid 41070997)
33. Thakur A, Sun Y, Bollig A, et al. Anti-invasive and antimetastatic activities of ribosomal protein S6 kinase 4 in breast cancer cells. Clin Cancer Res 2008;14:4427-4436
34. Itahana K, Campisi J, Dimri GP. Methods to detect biomarkers of cellular senescence: the senescence-associated β-galactosidase assay. Methods Mol Biol 2007;371:21-31. (Pubitemid 350183415)
35. Chang BD, Xuan Y, Broude EV, et al. Role of p53 and p21waf1/cip1in senescence-like terminal proliferation arrest induced in human tumor cells by chemotherapeutic drugs. Oncogene 1999;18:4808-4818 (Pubitemid 29423564)
36. Myohanen SK, Baylin SB, Herman JG. Hypermethylation can selectively silence individual p16ink4A alleles in neoplasia. Cancer Res 1998;58:591-593
37. Kohn M, Hameister H, Vogel M, Kehrer-Sawatzki H. Expression pattern of the Rsk2, Rsk4 and Pdk1 genes during murine embryogenesis. Gene Expr Patterns 2003;3:173-177
38. Dimri GP. What has senescence got to do with cancer? Cancer Cell 2005;7:505-512
39. Shay JW, Pereira-Smith OM, Wright WE. A role for both RB and p53 in the regulation of human cellular senescence. Exp Cell Res 1991;196:33-39
40. Itahana K, Dimri G, Campisi J. Regulation of cellular senescence by p53. Eur J Biochem 2001;268:2784-2791
41. Armengol G, Rojo F, Castellvi J, et al. 4E-binding protein 1: a key molecular funnel factor in human cancer with clinical implications. Cancer Res 2007;67:7551-7555 (Pubitemid 47281345)